Literature DB >> 17332152

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.

Andrew S Levey1, Josef Coresh, Tom Greene, Jane Marsh, Lesley A Stevens, John W Kusek, Frederick Van Lente.   

Abstract

PURPOSE: We sought to reexpress the 4-variable Modification of Diet in Renal Disease (MDRD) Study equation for estimation of glomerular filtration rate (GFR) using serum creatinine (S(cr)) standardized to reference methods.
METHODS: Serum specimens included creatinine reference materials prepared by the College of American Pathologists (CAP), traceable to primary reference material at the NIST, with assigned values traceable to isotope dilution mass spectrometry (IDMS), a calibration panel prepared by the Cleveland Clinic Research Laboratory (CCRL), and frozen samples from the MDRD Study. Split specimens were measured at the CCRL using the Roche enzymatic and Beckman CX3 kinetic alkaline picrate assays.
RESULTS: Roche enzymatic assay results on CAP samples were comparable to IDMS-assigned values. Beckman CX3 assay results in 2004-2005 were significantly higher than but highly correlated with simultaneous Roche enzymatic assay results (r(2) = 0.9994 on 40 CCRL samples) and showed minimal but significant upward drift from Beckman CX3 assay results during the MDRD Study in 1989-1991 (r(2) = 0.9987 in 253 samples). Combining these factors, standardized S(cr) = 0.95 x original MDRD Study S(cr). The reexpressed 4-variable MDRD Study equation for S(cr) (mg/dL) is GFR = 175 x standardized S(cr)(-1.154) x age(-0.203) x 1.212 (if black) x 0.742 (if female), and for S(cr) (micromol/L) is GFR = 30849 x standardized S(cr)(-1.154) x age(-0.203) x 1.212 (if black) x 0.742 (if female) [GFR in mL x min(-1) x (1.73 m(2))(-1)].
CONCLUSION: When the calibration of S(cr) methods is traceable to the S(cr) reference system, GFR should be estimated using the MDRD Study equation that has been reexpressed for standardized S(cr).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332152     DOI: 10.1373/clinchem.2006.077180

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  649 in total

1.  Sex-Related Disparities in CKD Progression.

Authors:  Ana C Ricardo; Wei Yang; Daohang Sha; Lawrence J Appel; Jing Chen; Marie Krousel-Wood; Anjella Manoharan; Susan Steigerwalt; Jackson Wright; Mahboob Rahman; Sylvia E Rosas; Milda Saunders; Kumar Sharma; Martha L Daviglus; James P Lash
Journal:  J Am Soc Nephrol       Date:  2018-12-03       Impact factor: 10.121

2.  Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations.

Authors:  Yuen-Ting Diana Kwong; Lesley A Stevens; Elizabeth Selvin; Yaping Lucy Zhang; Tom Greene; Frederick Van Lente; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2010-07       Impact factor: 8.860

3.  The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.

Authors:  Michael Haase; Prasad Devarajan; Anja Haase-Fielitz; Rinaldo Bellomo; Dinna N Cruz; Gebhard Wagener; Catherine D Krawczeski; Jay L Koyner; Patrick Murray; Michael Zappitelli; Stuart L Goldstein; Konstantinos Makris; Claudio Ronco; Johan Martensson; Claes-Roland Martling; Per Venge; Edward Siew; Lorraine B Ware; T Alp Ikizler; Peter R Mertens
Journal:  J Am Coll Cardiol       Date:  2011-04-26       Impact factor: 24.094

4.  Non-acute myocardial infarction-related causes of elevated high-sensitive troponin T in the emergency room: a cross-sectional analysis.

Authors:  Gregor Lindner; Carmen Andrea Pfortmueller; Christian Tasso Braun; Aristomenis Konstantinos Exadaktylos
Journal:  Intern Emerg Med       Date:  2013-12-11       Impact factor: 3.397

5.  For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics.

Authors:  Andrew D Rule; Kent R Bailey; Gary L Schwartz; Sundeep Khosla; John C Lieske; L Joseph Melton
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

6.  Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.

Authors:  Ayse L Mindikoglu; Antone R Opekun; William E Mitch; Laurence S Magder; Robert H Christenson; Thomas C Dowling; Matthew R Weir; Stephen L Seliger; Charles D Howell; Jean-Pierre Raufman; Abbas Rana; John A Goss; Saira A Khaderi; John M Vierling
Journal:  Dig Dis Sci       Date:  2018-02-01       Impact factor: 3.199

7.  Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.

Authors:  Hiroyuki Kobori; A Brent Alper; Rajesh Shenava; Akemi Katsurada; Toshie Saito; Naro Ohashi; Maki Urushihara; Kayoko Miyata; Ryousuke Satou; L Lee Hamm; L Gabriel Navar
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

8.  Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders.

Authors:  Daniel E Weiner; Keith Bartolomei; Tammy Scott; Lori Lyn Price; John L Griffith; Irwin Rosenberg; Andrew S Levey; Marshal F Folstein; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2008-12-12       Impact factor: 8.860

9.  Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.

Authors:  Csaba P Kovesdy; Kunihiro Matsushita; Yingying Sang; Nigel J Brunskill; Juan J Carrero; Gabriel Chodick; Takeshi Hasegawa; Hiddo L Heerspink; Atsushi Hirayama; Gijs W D Landman; Adeera Levin; Dorothea Nitsch; David C Wheeler; Josef Coresh; Stein I Hallan; Varda Shalev; Morgan E Grams
Journal:  Eur Heart J       Date:  2018-05-01       Impact factor: 29.983

10.  Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment After Liver Transplantation.

Authors:  Lisa B VanWagner; Samantha Montag; Lihui Zhao; Norrina B Allen; Donald M Lloyd-Jones; Arighno Das; Anton I Skaro; Samuel Hohmann; John J Friedewald; Josh Levitsky
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.